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hydrolysis at one TAP chain induces ATP binding at the other chain; this
leads to an alternating and interdependent catalysis of both NBDs.
Furthermore, our data suggest that the peptide-mediated undocking of MHC
class I is linked to the transport cycle of TAP by conformational signals
arising predominantly from TAP1.
Background tide binding have been reported for several ABC trans-
porters [10–13].Major histocompatibility complex (MHC) class I mole-
cules bind antigenic peptides in the ER and transport
Mutations that prevent nucleotide binding to the NBDsthem to the cell surface for recognition by cytotoxic T
of TAP inhibit the peptide binding capacity of the trans-cells. Most of these peptides are generated in the cytosol
porter, and this finding argues for a tight functional cou-and are translocated into the ER by the transporter associ-
pling of the NBDs and the peptide binding site [9]. More-ated with antigen processing (TAP). TAP is composed of
over, nucleotide and peptide binding to the transportertwo polypeptide chains, TAP1 and TAP2, [1, 2] and is a
seems to affect the overall conformation of the transportermember of the ATP binding cassette (ABC) transporter
[14]. Previously, we investigated the effect of nucleotidefamily [3]. TAP forms a loading complex with MHC class
binding on TAP function by generating “symmetrical”I molecules through a bridging protein, tapasin, and two
mutant TAP molecules in which both NBDs were defec-chaperones, calreticulin and ERp57 [4–6].
tive in nucleotide binding [9]. Our results suggested that
the binding and transport of peptide by TAP are kinet-
Like other ABC transporters, TAP has two transmem- ically coordinated with the binding of peptide to the MHC
brane and two highly conserved nucleotide binding do- class I molecule and the subsequent release of the MHC
mains (NBDs). The substrate transport of ABC transporters class I molecule from the loading complex.
is strictly ATP dependent [7–9]. Binding and hydrolysis of
nucleotides is thought to drive the transport process by Here, by introducing mutations into the NBDs of either
TAP1 or TAP2, we asked whether the two conservedtransducing conformational changes from the NBDs to
the transmembrane domains [10]. In support of this view, NBDs are equally involved in the peptide transport pro-
cess. We found that the binding and transport of peptidessubstantial conformational changes resulting from nucleo-
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Figure 1 by TAP depend on the ability of both NBDs to bind
nucleotides but that TAP1 and TAP2 are functionally
distinct. The nucleotide binding preferences of the two
chains are different, and homologous mutations in the
NBDs of the two TAP chains, neither of which affects
nucleotide binding, have radically different effects on
peptide transport. Furthermore, the undocking of assem-
bled MHC class I depends on conformational signals aris-
ing predominantly from TAP1. We present a working
model in which nucleotide binding by TAP coordinates
the uptake and subsequent peptide transport with the
binding, loading, and release of MHC class I molecules
from the TAP complex.
Results
Distinct nucleotide binding properties of TAP1 and TAP2
We showed earlier that symmetrical mutations of the con-
served glycines at position 1 and 6 of the Walker A motif
(GXXGXGKS/T, in the single-letter amino acid code) of
both TAP chains to valine or serine, both of which blocked
nucleotide binding, did not interfere with the formation
of the class I loading complex on TAP but blocked peptide
transport and, surprisingly, peptide binding of TAP [9].
Based on these studies, we asked whether the NBDs
of the two TAP chains are functionally equivalent by
expressing in the TAP-deficient human cell line T2 asym-
metrical combinations of rat wild-type TAP1 together
with mutant TAP2 or vice versa. Glycine-to-valine and
glycine-to-serine mutations in the Walker A motif were
termed, respectively, mutations I and II [9]. T2 transfec-
tants were termed as follows: T2–1/2 I (mutation I in
TAP2), T2–2/1 I (mutation I in TAP1), T2–1/2 II (muta-
tion II in TAP2), and T2–2/1 II (mutation II in TAP1).
Western blot analysis confirmed the expression of both
TAP chains at comparable levels in all transfectants. Fur-
Nucleotide binding properties of TAP1 and TAP2. (a) Nucleotide ther, mutating the NBD of TAP1 or TAP2 had no appar-
binding properties of wild-type and mutant TAP. Membranes of T2 ent effect on the stability of the TAP heterodimer or the
transfectants (corresponding to 1 3 107 cells) were resuspended in
formation of the loading complex (see Figure S1 available250 ml lysis buffer and incubated with different nucleotide-agaroses.
with this article on the internet).Control lysates correspond to 2 3 105 cells. After washing the
nucleotide-agarose, we eluted bound proteins with SDS sample
buffer and analyzed them in Western blots probed for rat TAP1 and To compare the nucleotide binding capacities of wild-
TAP2. It should be noted that only isolated membrane fractions
type TAP with the different asymmetrical TAP mutants,could be used for these kind of experiments since total cell lysates
gave nonspecific TAP binding to nucleotide-agaroses (O. D. and we performed nucleotide binding assays [9]. The binding
M. R. K., unpublished data). (b) ATP binding capacity of TAP1 and of TAP to nucleotide-agarose was visualized on Western
TAP2 in wild-type transporter. Membrane fractions of T2 and blots probed for TAP1 and TAP2. As shown previouslyT2-TAPwt cells were incubated with 3 ml 8-azido-ATP[g-32P] at 48C
[9], wild-type TAP bound to ADP- and ATP- but not tofor 1 min. In a control sample, the interaction of TAP with 8-azido-
ATP[g-32P] was competitively inhibited by the addition of 5 mM ATP. AMP-agarose (Figure 1a). All the asymmetric TAP vari-
After UV crosslinking, membranes were lysed in Triton X-100, and ants bound ADP- but not AMP-agarose. However, they
TAP was immunoprecipitated with anti-rat TAP2 antiserum (right panel) differed markedly in their ability to bind ATP-agarose.and separated on a 7.5% SDS gel. For identification of the TAP1 and
TAP2 chains, lysates of T2-TAPwt, T2-TAP1 (expressing only TAP1),
and T2-TAP2 (expressing only TAP2) were analyzed by a Western
blot probed for rat TAP2 and TAP1 (left panel). (c) Nucleotide binding
nucleotide-agarose, we eluted proteins with SDS sample buffer andproperties of isolated TAP subunits. Membrane fractions of T2
analyzed them in Western blots probed for rat TAP2 and TAP1.transfectants (corresponding to 1 3 107 cells) expressing single
Control lysates correspond to 2 3 105 cells.wild-type TAP chains were resuspended in 250 ml lysis buffer and
incubated with different nucleotide-agaroses. After washing the
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Figure 2Those variants carrying mutations in the NBD of the
TAP2 chain (1/2 I and 1/2 II) bound ATP-agarose as well
as the wild type did. In contrast, transporters carrying
mutations in the TAP1 chain (2/1 I and 2/1 II) did not
bind ATP-agarose at all, despite having bound ADP-aga-
rose well. We therefore suggest that only TAP1 has a
high-affinity ATP binding site in the resting molecule.
In order to test this notion, we investigated nucleo-
tide binding by TAP1 and TAP2 in wild-type TAP by
using photolabeling with free 8-azido-ATP[g-32P]. Isolated
membranes of T2-TAPwt were incubated with 8-azido-
ATP[g-32P], protein bound nucleotides were crosslinked
by UV irradiation, and TAP was immunoisolated from
lysates. The labeling efficiency for TAP1 was markedly
higher than for TAP2 (Figure 1b). Phosphorimager quan-
titation revealed that 90% of the activity is located in
TAP1 and only 10% in TAP2. The distribution of labeling
should represent the ATP binding capacities of TAP
chains in a functional heterodimer because TAP1 chains
were coisolated in anti-TAP2 immunoprecipitates. We
wondered whether the distinct nucleotide binding behav-
iors of the two chains in the heterodimeric complex re-
Nucleotide binding of both TAP chains is required for TAP’s transportflected intrinsic properties of the individual TAP sub-
activity. (a) TAP-mediated peptide transport. Transfected andunits. Therefore, detergent-solubilized membranes from
nontransfected T2 cells were permeabilized with streptolysin O and
T2 transfectants expressing only TAP1 or TAP2 were were incubated with 10 mM ATP and radioiodinated peptide S8
incubated with the nucleotide-agarose resins and assayed (1.3 3 106 cpm). The graph shows the recovered amount of
transported labeled peptides as counts per minute (cpm). (b)as before (Figure 1c). Single TAP1 chains were bound to
Surface expression of class I molecules. Cells were incubated withagarose-immobilized ATP and ADP but not to AMP. ADP
mAb 4E that recognizes HLA-B5. After we incubated cells with a
binding was also demonstrable for the TAP2 chains, but FITC-labeled secondary antibody, the surface expression of HLA-B5
we observed nearly no binding to ATP-agarose. Single was detected by flow cytometry (filled histograms). We determined
background staining by incubating with secondary antibody onlyTAP chains appeared to bind to nucleotide-agaroses less
(nonfilled histograms).efficiently than did the wild-type transporter relative to
lysate controls. Nevertheless, the properties of the indi-
vidual TAP chains from single-chain transfectants re-
flected the properties of the chains inferred from their results show that the integrity of both NBDs is required
behavior in TAP heterodimers. In summary, these data for the transport activity of TAP, as has been shown for
suggest that the observed ATP binding of resting TAP other ABC transporters [15].
is mediated predominantly by TAP1, while both subunits
of TAP contribute to the observed ADP binding activity. Peptide uptake by TAP depends on nucleotide binding
[9]. To analyze whether the NBDs of both TAP chains
Binding and transport of peptides by TAP depend contribute to the nucleotide dependency of peptide bind-
on functionality of both NBDs ing, we incubated permeabilized cells of the various T2
Recent data provided evidence that peptide binding and cell lines with photoreactive, radioiodinated peptide S8.
transport by TAP are abrogated when both NBDs are After UV crosslinking, immunoisolated TAP was sepa-
defective in nucleotide binding [9]. To assess the individ- rated by SDS-PAGE. Crosslinking of radiolabeled pep-
ual contributions of the two chains to these activities, we tide S8 to TAP was detectable for the wild-type trans-
performed a standard transport assay with the asymmetri- porter but negligible for all of the mutant transporters
cal TAP mutants by using iodinated model peptide S8 (Figure 3). Thus, nucleotide binding in both TAP chains
(TVDNKTRYR, in the single-letter amino acid code) [9]. is required for the uptake of peptide by the transporter.
In contrast to wild-type TAP, no peptide transport above
background could be detected for any mutant TAP (Fig- Peptide-mediated disassembly of the TAP–MHC class I
ure 2a). The TAP mutants’ lack of transport activity was complex depends mainly on nucleotide binding by TAP1
confirmed when the surface expression of HLA-B5 was We previously showed that peptide-induced dissociation
analyzed by FACS (Figure 2b). T2 cells expressing mu- of the TAP–MHC class I complex is blocked in symmetri-
tant TAP variants had levels of HLA-B5 surface expres- cal TAP NBD mutants [9]. It was therefore of interest to
see whether the implied conformational effects of nucleo-sion no greater than that of untransfected T2 cells. These
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Figure 3 It has been suggested that nucleotide dissociation from
TAP reduces its thermal stability [14] and that irreversible
changes in TAP conformation induced by incubation at
378C can be prevented by nucleotide binding to TAP1.
It was possible that such conformational injury to nucleo-
tide-free transporters might have contributed to the block
of peptide-dependent class I release in symmetrical [9]
and asymmetrical TAP NBD mutants. We therefore in-
vestigated peptide-dependent class I MHC dissociation
from TAP in solubilized T2-TAPwt cells which had been
depleted of ATP in vivo by incubation with antimycin A
and 2-deoxyglucose [16]. Treatment with both metabolic
inhibitors caused a drastic decrease in the cellular ATP
level of T2-TAPwt cells. After 45 min incubation at 378C,
the cellular ATP pool was almost completely depleted
(data not shown). Cells, treated with antimycin A and
Nucleotide binding by both TAP chains is required for peptide uptake 2-deoxyglucose, were lysed in 1% digitonin and incubated
by the transporter. Streptolysin O–permeabilized cells were
for 60 min at 378C with or without A2/B5 peptides in theresuspended in binding buffer and incubated with 1 mM radioiodinated
absence or presence of 3 mM MgATP. Immunoisolatedand HSAB-conjugated peptide S8. After crosslinking, cells were
lysed and TAP was immunoprecipitated from postnuclear supernatants TAP complexes were analyzed by Western blots probed
with anti-rat TAP2 (upper part). The amount of TAP was controlled for TAP2 and class I heavy chains. The peptide-mediatedby an anti-rat TAP2 Western blot of the corresponding lysates (lower
release of class I molecules was substantially blocked inpart).
nucleotide-depleted lysates (Figure 4b). Most notably,
the addition of 3 mM MgATP eliminated this effect.
MgATP without peptide gave only a slight reduction intide binding on breakdown of the loading complex could
the signal of coisolated class I molecules; this reductionbe specifically attributed to one chain of TAP. Digitonin-
was perhaps caused by a small population of complexessolubilized cells of T2 transfectants carrying the various
in the cells in which TAP-bound class I molecules areasymmetrical TAP NBD mutants were incubated with a
already loaded with peptides [17]. In summary, the block1:1 mixture of HLA-A2 and HLA-B5 binding peptides
in class I release from TAP in the absence of nucleotides isat 378C for 60 min [9]. After immunoisolation of TAP
not secondary to an irreversible, temperature-dependentcomplexes with anti-TAP2 antiserum, coisolation of MHC
structural change in the conformation of nucleotide-freeclass I was analyzed by Western blotting with a mono-
transporters.clonal antibody against HLA-A and -B molecules (Figure
4a). MHC class I molecules that were associated with
TAP1 and TAP2 serve different functionswild-type TAP were released nearly completely by incu-
during peptide transportbation with peptides (approximately 90% reduction of the
Asymmetrical TAP NBD variants deficient in nucleotideclass I signal). Complexes of MHC class I and mutant
binding reveal distinct properties of TAP1 and TAP2 inTAPs carrying wild-type TAP1 (TAP1/2 I and TAP1/2
both nucleotide binding and peptide-mediated class III) showed peptide-mediated dissociation comparable to
release; this finding suggests that the subunits fulfil dis-that of the wild-type complex. However, asymmetrical
tinct functions during the transport cycle. We next wantedTAP mutants with mutant TAP1 (TAP2/1 I or TAP2/1
to examine mutations in the Walker A motif of TAP1 andII) showed only a partial release of class I molecules by
TAP2 that should not affect nucleotide binding but thatpeptides. Quantification of the class I signals by microden-
might interfere with the catalytic activity of the NBDs.sitometry obtained for TAP2/1 I or 2/1 II revealed that
Residues at position 2 and 3 of the Walker A motif displayonly 30%–50% of associated MHC class I molecules are
considerable sequence variation within different GTPasesreleased from the TAP complex upon incubation with
and ATPases [18] and seem to have functional impor-peptides. Since TAP2/1 I and 2/1 II show persistent affin-
tance, as has been shown for nucleotide binding proteinsity for ADP (Figure 1a), we asked whether the partial
such as adenylate kinase and p21ras [19, 20]. It has beeninhibition of the dissociation process could be due to
speculated that sequence variations in the Walker A motiflimiting concentrations of ADP in the cell lysates. How-
reflect adaptation to distinct catalytic functions of differ-ever, the external addition of even 1 mM ADP or ATP
ent nucleotide binding proteins [18]. Therefore, we re-did not boost peptide-mediated class I release for either
placed the residues proline and asparagine in the WalkerTAP2/1 I or TAP2/1 II (data not shown). Thus, the nucleo-
A site at positions 2 and 3 with serine, which can be foundtide dependency of peptide-mediated TAP/MHC I disso-
in the same positions in other prokaryotic and eukaryoticciation seems to be mainly controlled by the nucleotide
binding state of TAP1. ABC transporters [3, 15].
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Figure 4
Mutations in the NBD of TAP1 affect peptide-
mediated release of class I molecules from
TAP. (a) Peptide-mediated dissociation of the
TAP complex. Digitonin-solubilized T2
transfectants were incubated for 60 min at
378C with a 100 mM 1:1 mixture of HLA-A2
(peptide A2) and HLA-B5 (peptide B5)
binding peptides. TAP complexes were
immunoprecipitated with anti-rat TAP2 and
analyzed by Western blot. The upper part of
the blot was immunostained with anti-rat
TAP2, and the lower part was immunostained
with anti-human class I (3B10.7). (b) Effect of
in vivo ATP depletion on complex
dissociation. Equal amounts of T2-TAPwt cells
were cultured for 45 min at 378C in glucose-
free RPMI1640 containing 2-deoxyglucose
and antimycin A at final concentrations of 20
mM and 50 mM, respectively. Cells were
harvested by centrifugation and lysed with
1% digitonin. Lysates were incubated for 60
min at 378C with or without A2/B5 peptide
mixture in the absence or presence of 3 mM
MgATP. Immunoisolated TAP complexes
were analyzed by Western blot (left panel).
The upper part of the blot was developed
with anti-TAP2 (116/5), and the lower part
was developed with anti–class I (3B10.7)
antiserum. ECL-fluorographs of TAP and MHC
class I heavy chains were quantified by
densitometric scanning. Peak integrals of TAP
(gray bars) and MHC class I heavy chains
(black bars) were plotted in arbitrary units
(right panel).
This TAP mutation is referred to as MUT III. TAP vari- pressing MUT III in both chains showed a transport activ-
ity reduced by 50% relative to wild-type TAP, while theants carrying MUT III in either TAP1, TAP2, or both
chains were transfected stably into T2 cells. The resulting two asymmetrical MUT III mutants differed radically
from each other. When the MUT III mutation was onlyasymmetrical transfectants, which we have designated
T2–1/2 III (MUT III in TAP2) and T2–2/1 III (MUT in the TAP1 chain (TAP2/1 III), the transport activity of
TAP was, if anything, even more efficient than that ofIII in TAP1), and the symmetrical mutant T2-MUT III
(both TAP chains mutated) were tested for TAP expres- the wild type, while the transport activity of TAP1/2 III
was drastically decreased (approximately 10% of the wild-sion by Western blot analysis. All cell lines expressed
both TAP chains in amounts comparable to that of T2- type transporter). The different peptide transport activi-
ties were also reflected in different HLA-B5 surface ex-TAPwt and formed loading complexes (Figure S2). Nu-
cleotide binding of the different TAP variants was ana- pression levels determined by FACS analysis (Figure 6b).
However, neither T2-Mut III nor T2–1/2 III showed alyzed as described above (Figure 1) and showed that
introduction of the eukaryotic consensus sequence into the defect in peptide binding (Figure S3).
Walker A motif had no effect on the nucleotide binding
In summary, MUT III has strikingly different effects oncapacity of the transporter (Figure 5). Both asymmetrical
peptide transport activity depending on whether it is pres-and symmetrical MUT III TAP NBD mutants showed
ent in the Walker A sequence of TAP1 or of TAP2, andwild-type levels of binding to ADP- and ATP-agarose.
these results strongly suggest that the TAP chains serveFurthermore, single expressed TAP1 and TAP2 chains
different functions during the transport process. Further-carrying MUT III have the same nucleotide binding pref-
more, the fact that the presence of MUT III in both TAPerences as do the corresponding wild-type TAP chains
chains leads to transport activity intermediate between(data not shown and Figure 1c).
that of TAP1/2 III and TAP2/1 III supports the view of
an interdependent action of both TAP chains during theThe MUT III mutation had striking effects on peptide
transport (Figure 6a). The symmetrical TAP variant ex- transport cycle.
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Figure 5 binding for the single chains is much lower than for the
TAP heterodimers, which indicates that subunit assembly
favors correct domain folding. Nevertheless, the differen-
tial nucleotide binding properties of TAP1 and TAP2 are
determined at least in part by intrinsic properties of the
TAP chains. These results suggest that, under experimen-
tal conditions not allowing nucleotide hydrolysis, ATP
binding to TAP is mediated by TAP1, while TAP2 is
barely accessible for ATP. A possible explanation of this
phenotype could be that ATP is tightly bound by the
NBD of TAP2; therefore, ATP binding to TAP 2 could
not be detected with the methods applied here. Still,
ADP binding to TAP2 was clearly detectable, which indi-
cates that the NBD of TAP2 is accessible for nucleotides
and speaks in favor of a specific mechanism to prevent
ATP binding to TAP 2 in the ground state of the trans-
porter. Russ et al. [21] also found pronounced labeling
of human TAP1 with 8-azido-ATP but attributed it to
differences in the expression level of TAP1 and TAP2
in their experimental system and concluded that TAP1
and TAP2 may well have similar affinities for ATP. Our
findings on rat TAP suggest that the nucleotide binding
behavior of human TAP should be reinvestigated.
Studies on P-glycoprotein report differences in ATP bind-
ing to the N- and C-terminal NBD. Specific chemical
modification of the N-terminal NBD strongly inhibited
ATP binding, while modification of the C-terminal NBD
had no effect on ATP binding [22]. Hrycyna et al. [23]
showed under conditions that prevent ATP hydrolysis
that P-glycoprotein binds ATP predominantly with the
N-terminal NBD. However, under conditions that allow
hydrolysis, the C-terminal NBD was preferentially la-
Nucleotide binding properties of wild-type TAP and the mutant TAP beled with 8-azido-ATP. The authors concluded that the
variants MUT III, 1/2 III, and 2/1 III. Membrane fractions of T2
two NBDs are functionally asymmetric [23]. A similartransfectants were resuspended in lysis buffer and incubated with
different nucleotide-agaroses (Figure 1a). After washing the view is emerging from studies of cystic fibrosis transmem-
nucleotide-agarose, we eluted proteins with SDS sample buffer and brane conductance regulator (CFTR) [24, 25, 26]. Fur-
analyzed in Western blots probed for rat TAP2. Control lysates thermore, despite forming homodimers, the NBD sub-correspond to 5 3 104 cells.
units of bacterial permeases have also been found to show
functional and structural nonequivalence [27, 28]. Our
results on TAP are fully consistent with a general model
of the hydrolytic cycle for single-chain, tandem ABCDiscussion
transporters, such as CFTR, in which hydrolysis of ATPAlthough the two NBDs of TAP show high sequence
at one NBD initiates ATP binding and, subsequently,homology, it is unclear whether they fulfill functionally
hydrolysis at the second NBD [29]. Since we found pre-equivalent or distinct roles during the transport cycle. We
dominant labeling for ATP of the TAP1 chain, it is tempt-have used TAP variants in which only one of two TAP
ing to speculate that it is TAP 1 that initiates the transportchains carried mutations in the ATP binding site to show
cycle of TAP after peptide binding. Upon hydrolysis ofthat TAP1 and TAP2 have distinct biochemical and func-
tional properties in the transporter. ATP at TAP 1, the NBD of TAP 2 would become accessi-
ble for ATP. ATP binding and hydrolysis at TAP 2 might
in turn be necessary to complete the transport cycle.The nucleotide binding capacities of TAP1 and TAP2
are different. ATP bound almost exclusively to TAP1 in
In our previous study, we observed that mutational dam-the TAP heterodimer (Figure 1b), and TAP1 molecules
age to the two nucleotide binding sites also preventedfrom single-chain transfectants bound both ATP and
peptide binding by TAP [9]. Here we show that bothADP, while TAP2 from single-chain transfectants bound
only ADP (Figure 1c). The overall efficiency of nucleotide NBDs have to be functional for peptide uptake (Figure
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Figure 6 3). Cooperative formation of the peptide binding site by
both TAP1 and TAP2 was also inferred previously from
crosslinking studies with peptides [30, 31]. It has recently
been shown that the presence of peptides in the cytosol
slows down TAP’s lateral movement [32]. Interestingly,
the effect is nucleotide dependent but not transport de-
pendent, and this finding suggests that the peptide bind-
ing activity of TAP in vivo is dependent on the presence
of nucleotides. Our experiments indicate conformational
crosstalk between peptide and nucleotide binding sites,
and this is consistent with accumulating evidence that
substrate binding by ABC transporters may initiate ATP
hydrolysis [15]. There is evidence from P-glycoprotein
that the affinity for substrate drops transiently during
the catalytic cycle [33]. It is therefore plausible that the
conformation of TAP carrying NBD mutations in TAP1
or TAP2 may resemble a conformation reached transiently
during the normal transport cycle, presumably during the
predicted transient empty state after hydrolysis during
ADP-to-ATP exchange [29].
Thus, in TAP as in other ABC transporters, nucleotides
perform as allosteric regulators by mediating different
conformational states in the substrate binding site, a func-
tion distinct from their role in using the energy of ATP
hydrolysis to drive peptide transport. This allosteric regu-
lation also affects the interaction of TAP with MHC class
I molecules. Li et al. [17] demonstrated that peptide-
loaded MHC class I molecules are released from the load-
ing complex by incubation with ATP. We found that the
peptide-mediated dissociation of MHC class I molecules
from the loading complex was blocked when both NBDs
were functionally disrupted [9]. Now we show that this
block arises mainly from TAP1 (Figure 5). TAP-associ-
ated class I MHC molecules are bound preferentially (pre-
sumably with tapasin) through TAP1 [34], though interac-
tion with both TAP chains has also been claimed [35]. It
is thus not clear whether the conformational effect of
nucleotide binding by TAP1 is indeed a local effect or is
transduced to TAP2 as well. Nucleotide binding by TAP1
may cause changes in the overall conformation of the
transporter [14].
The remarkable properties of the nondestructive P loop
mutation MUT III strongly support the view that the
two TAP chains function asymmetrically in the transport
cycle. The mutation does not affect nucleotide binding
by either chain, and it is consistent with our previous
discussion in that peptide binding is also not impaired.
However, the mutation essentially disables the trans-Nonequivalent function of TAP chains in the transport cycle. (a) TAP-
mediated peptide transport. Transfected and nontransfected T2 cells
were permeabilized with streptolysin O and incubated with 10 mM
ATP and radioiodinated peptide S8 (1.3 3 106 cpm) for 0, 4, and
surface expression of HLA-B5 was detected by flow cytometry (filled8 min. The graph shows the recovered amount of transported labeled
histograms). We determined background staining by incubating cellspeptides as counts per minute (cpm). (b) Surface expression of
only with secondary antibody (nonfilled histograms).class I molecules. Cells were incubated with mAb 4E that recognizes
HLA-B5. After incubation with a FITC-labeled secondary antibody,
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Figure 7porter when it is present only in TAP2, while, if anything,
increasing its activity relative to the wild type when it is
present only in TAP1. These data show that the TAP-
specific residues at positions 2 and 3 of the Walker A
domain are of functional importance since they cannot be
replaced by serines, which are frequently found in other
eukaryotic and prokaryotic ABC transporters. That a deli-
cate interactive property of the transporter has been al-
tered by MUT III seems to follow also from the fact that
the severe phenotype of MUT III in TAP2 is largely
reverted by the parallel presence of MUT III in TAP1.
It will be of interest to find out whether this is a TAP-
specific phenomenon or whether the sequence variations
at these positions that are seen between different ABC
transporter families are of general importance. Results
from mutations in the Walker A domain of the GTPase
p21ras and the ATPase adenylate cyclase might speak in
favor of the latter assumption [18]. Our current data on
mutation III do not allow an interpretation of the potential
effect of this mutation on the activity of TAP. Neverthe-
less, they clearly point at structural differences between
the NBDs of TAP1 and TAP2, and these differences
support our view that TAP1 and TAP2 serve different
Working model of the TAP transport cycle. TAP in the ground state
functions during the translocation of peptides by TAP. binds ATP with TAP1 and ADP with TAP2 and is competent for
ATP binding to TAP2 is hardly detectable under our peptide binding (step 1). Hydrolysis at TAP1 and nucleotide exchange
at TAP2 could then initiate and energize the process of peptideexperimental conditions (Figure 1b), even though it is
transport (steps 2 and 3). In the putative “nucleotide-off configuration”generally believed that ATP binding and hydrolysis by
TAP2 is in a nucleotide-free state (step 2). This hypothetical, transient
both NBDs occur in ABC transporters. Thus, MUT III step might be related to the ATP or ADP bound states of TAP1/2 I
might interfere with conformational changes in TAP2 that and TAP1/2 II. The recovery phase could be then initiated upon
hydrolysis at TAP2 and nucleotide exchange in TAP1. Thus, alternatingoccur during the transport cycle of TAP and that are
activity of NBD1 and NBD2 powers transport and recovery phases,necessary to allow ATP binding and hydrolysis.
respectively. The postulated “nucleotide-off configuration” in the
second half on the cycle is characterized by the nucleotide-free
In Figure 7 we present a working model of the TAP state of TAP1 (step 4). We assume that this proposed transient stage
might be related to the nonpermissive TAP-MHC complexes oftransport cycle as a platform for future work. The underly-
TAP2/1 I and TAP2/1 II in that it could allow peptides to inspect alling hypothesis is that nucleotide binding and hydrolysis
bound class I molecules for compatibility. After returning to the initial
by TAP coordinates the uptake and subsequent transport ground state (step 5), successfully loaded MHC molecules could be
released, and the transporter would be in a peptide-competentof peptides with the binding, loading, and release of MHC
conformation again (steps 1 and 5). The ground states for which weclass I molecules in the TAP loading complex. Step 1 of
have experimental evidence are indicated by colors, while theFigure 7 describes a putative starting point for the trans- transitional states of the transport cycle that remain speculative are
port cycle, with ATP bound to TAP1 and ADP bound to shown in gray. Nucleotides that are bound to TAP are indicated by
T (ATP), D (ADP), and N (ATP or ADP). For simplification, only oneTAP2. This state is permissive for peptide binding and
MHC class I–tapasin subcomplex is shown in the transport cycle.initiates ATP hydrolysis, perhaps as a result of peptide
binding. It is postulated that ATP hydrolysis at TAP1
initiates peptide transport and releases ADP from TAP2
and that this leads to Step 2, with nucleotide bound by of class I molecules from the loading complex. If multiple
TAP1 and a transient “nucleotide-off” state for TAP2 class I molecules are associated with a single loading com-
assumed in other models of ABC transport [29]. The entry plex [5], this “pause” in the transport cycle could provide
of ATP into the catalytic site of TAP2 (step 3) and its an opportunity for the released peptide to sample different
subsequent hydrolysis (step 4) completes peptide trans- class I allelic products. After the recharging of TAP1 with
port and initiates the recovery phase, entailing release of ATP, the transporter approaches the ground state, releases
ADP from TAP1 and a second transient “nucleotide-off” successfully loaded class I molecules (step 5), and associates
state for TAP1. We propose that this state corresponds with a free, unloaded class I molecule in anticipation of
(although it is evidently not identical) to the nonpermis- the next transport cycle. It must be stressed that the model
sive state of the loading complex, described in Figure 4, urgently needs direct experimental evidence for the exis-
in which, in the absence of nucleotide binding by TAP1, tence of the ATP bound and hydrolytically active state of
TAP2 that is represented by steps 3 and 4.peptide binding to class I molecules fails to induce release
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X-100 [Sigma]). Immunoprecipitations with anti-rat TAP2 (116/5) wereIt will be of interest to find out how the asymmetry in
performed as described previously [41]. For the characterization of TAPnucleotide binding between TAP1 and TAP2 is deter-
complexes, anti-rat TAP2 antiserum (116/5) was covalently coupled to
mined. Our own data show that sequences of the transmem- protein A–sepharose (Amersham) with the help of dimethylpimelimidate
brane domains do not influence the nucleotide binding of [42]. Digitonin lysates were incubated with matrix-coupled antibodies
for 90 min at 48C. Precipitates were washed five times with TBS con-TAP1 and TAP2 and suggest that intrinsic properties of the
taining 0.1% digitonin and eluted competitively with 10 mM syntheticNBDs determine the different nucleotide binding behavior
peptide (EMBL-732) [41]. Samples were separated by SDS-PAGE and
(O. D. and M. R. K., unpublished data). analyzed by Western blot treated with specific primary antibody. Bands
were visualized with horseradish peroxidase–conjugated goat anti-rabbit
or goat anti-rat IgG and enhanced-chemiluminescence (ECL) substrateConclusions
(Amersham). For signal quantification, fluorographs were scanned byOur results confirm a role for nucleotides as allosteric
microdensitometry with a Joyce-Loebel Chromoscan II (Joyce-Loebel).
effectors modifying the conformation of TAP during the
transport cycle. For the uptake of peptide, it is critically Transport and peptide crosslinking assay
important that both TAP subunits are in a nucleotide Both assays were performed as described before [9].
bound state, whereas the undocking of loaded MHC class
Nucleotide binding assayI molecules is mainly regulated by the nucleotide binding
The nucleotide binding assay was performed as described previouslystate of TAP1. Furthermore, our findings indicate that at
[9]. Photolabeling of TAP with 8-azido-ATP[g-32P] was performed ac-resting state ATP is bound to the NBD of TAP1, while cording to Russ and coworkers [21]. Membranes of cells were prepared
ADP is bound to the NBD of TAP2. This would be as described above and were resuspended in 250 mM sucrose, 50 mM
KCl, 2 mM MgCl2, 2 mM EGTA and 10 mM Tris (pH 6.8). Membranesconsistent with a model in which both NBDs bind and
corresponding to 3 3 106 cells in a final volume of 100 ml were incubatedhydrolyze ATP in an alternating and interdependent man-
with 3 ml 8-azido-ATP[g-32P] (ICN Biomedicals) for 1 min on ice. Cross-ner and thereby control different steps in the transport linking was induced by irradiation with a UV lamp at 254 nm for 5 min
process. Supporting this view, we could demonstrate that on ice. Samples were diluted to 1 ml with lysis buffer containing 1%
Triton X-100, and immunoprecipitation with anti-TAP2 antiserum wasidentical mutations in the NBD of TAP1 and TAP2 lead
performed as described above. We separated immunoisolated materialto a strikingly different transport activity. Thus, the two
with SDS-PAGE, and we visualized reactive species by exposing theNBDs seem to serve distinct functions during the trans- dried gels to phosphorimager screens and by fluorography.
port cycle.
Flow cytometry
Flow cytometry was performed as described previously [9].Materials and methods
Cell lines and cell culture
Note added in proofT2 is a human lymphoblastoid cell line that lacks both TAP genes and
While our manuscript was in review, Lapinski et al. [43] published a character-expresses only HLA-A2 and -B5 class I molecules [36]. Transfectants
ization of Walker A lysine mutations of TAP1 and TAP2. The authors showof T2 containing rat TAP1a and rat TAP2a, which have been described
that mutation K607M in TAP1 and K509M in TAP2, which are differentpreviously [37], were cultured in IMDM (Gibco BRL) supplemented with
from our mutations, have distinct effects on nucleotide binding and peptide10% FCS (BIO Whittaker) and 1 mg/ml G418 (PAA, Co¨lbe). transport. From their results the authors suggest that nucleotide binding to
TAP 1 is not a requirement for peptide binding to the TAP complex. Further-
more, in contrast to our view, they postulate that TAP2 constitutes the firstCloning and expression of mutant TAP
ATP hydrolysis and that TAP1 is required to reset the transporter for anotherMutagenesis of the Walker A site in rat TAP2a and TAP1a cDNA [38,
cycle.39] with the mutations I and II was performed as previously described
[9]. We performed mutagenesis of the Walker A site in rat TAP2a and
Supplementary materialTAP1a cDNA with the mutation III by using the pALTER-1 in vitro mutagen-
Supplementary material, including three supplementary figures and addi-esis system (Promega) according to the manufacturer’s instructions. The
tional Materials and methods, is available with the electronic version ofmutagenic oligonucleotide was as follows: MUT III, GGTGCTCTTCGCT
this article at http://www.current-biology.com/supmatin.htm.GACCCACTGGATCCCACCAAAGC. The mutated constructs were ex-
cised with EcoRI and subcloned in the expression vector pHbAPr-1-
Acknowledgementsneo [40]. TAP2a and TAP1a constructs present in pHbAPr-1-neo were
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